...
首页> 外文期刊>Materials science & engineering, C. Materials for Biogical applications >Evaluation of the potential of chimeric spidroins/poly(L-lactic-co-epsilon-caprolactone) (PLCL) nanofibrous scaffolds for tissue engineering
【24h】

Evaluation of the potential of chimeric spidroins/poly(L-lactic-co-epsilon-caprolactone) (PLCL) nanofibrous scaffolds for tissue engineering

机译:评价嵌合孢子苷/聚(L-乳酸 - ε-己内酯)(PLCL)组织工程纳米纤维支架的潜力

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

In this study, a novel type of chimeric spider silk proteins (spidroins) NTW1-4CT was blended with poly(L-lactic-co-epsilon-caprolactone) (PLCL) to obtain nanofibrous scaffolds via electrospinning. Spidroins are composed of a Nterminal module (NT) from major ampullate spidroins, a C-terminal module (CT) from minor ampullate spidroins and 1-4 repeat modules (W) from aciniform spidroins. Physical characteristics and structures of NTW1-4CT/PLCL (25/75, w/w) blend scaffolds were carried out by scanning electron microscope (SEM), water contact angles measurements, Fourier transform infrared (FTIR) spectroscopy and tensile mechanical tests. Results showed that blending with spidroins decreased diameters of nanofibers and increased porosity and wettability of scaffolds. Additionally, chimeric spidroins undergone a similar structural transition in electrospinning process as with the formation process of native and artificial spider silks from other spidroins. With amounts of W modules increasing, the tensile strength and elongation of blend scaffolds were also increased. Particularly, NTW4CT/PLCL (25/75) scaffolds revealed much higher breaking stress than pure PLCL scaffolds. In vitro experiments, human umbilical vein endothelial cells (HUVEC) cultured on NTW4CT/PLCL (25/75) scaffolds displayed significantly higher activity of proliferation and adhesion than on pure PLCL scaffolds. All results suggested that chimeric spidroins/PLCL, especially NTW4CT/PLCL (25/75) blend nanofibrous scaffolds had promising potential for vascular tissue engineering.
机译:在该研究中,将一种新型的嵌合蜘蛛丝蛋白(蜘蛛)NTW1-4CT与聚(L-乳酸 - ε-己内酯)(PLCL)共混,通过电刺刺激获得纳米纤维支架。蜘蛛素由来自主要Ampullate蜘蛛的缠绕模块(NT)组成,来自次氨疹蜘蛛的C末端模块(CT)和1-4个重复模块(W)来自癌型蜘蛛素。通过扫描电子显微镜(SEM)进行NTW1-4CT / PLCL(25/75,W / W)混合支架的物理特性和结构,水接触角测量,傅里叶变换红外(FTIR)光谱和拉伸机械测试。结果表明,与蜘蛛蛋白的混合降低了纳米纤维的直径,以及增加支架的孔隙率和润湿性。另外,嵌合蜘蛛素在静电纺丝过程中经历了类似的结构转变,与其他蜘蛛素的土着和人造蜘蛛丝网的形成过程一样。随着W模块的增加,增加了混合物支架的拉伸强度和伸长率。特别地,NTW4CT / PLCL(25/75)支架显示出比纯PLCL支架的断裂应力更高。体外实验,在NTW4CT / PLCL(25/75)上培养的人脐静脉内皮细胞(HUVEC)显着更高的增殖和粘附活性,而不是纯PLCL支架。所有结果表明,嵌合孢子苷/ PLCL,尤其是NTW4CT / PLCL(25/75)共混纳米纤维支架对血管组织工程有希望的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号